Delergotrile
| Delergotrile_structure.png | |
Delergotrile is a chemical compound that has been studied for its potential use as a pharmaceutical drug. It belongs to the class of ergoline derivatives, which are known for their diverse pharmacological activities. Delergotrile has been primarily investigated for its effects on the dopaminergic system and its potential use in treating conditions such as Parkinson's disease and prolactinomas.
Pharmacology[edit | edit source]
Delergotrile acts as a dopamine receptor agonist, meaning it binds to and activates dopamine receptors in the brain. This action can help to restore the balance of dopamine, a neurotransmitter that is often deficient in certain neurological disorders. The drug has a high affinity for the D2 subtype of dopamine receptors, which are primarily involved in the regulation of movement and endocrine functions.
Mechanism of Action[edit | edit source]
The primary mechanism of action of Delergotrile involves its interaction with the D2 dopamine receptors. By stimulating these receptors, Delergotrile can mimic the effects of dopamine, leading to improved motor control and reduced symptoms in conditions like Parkinson's disease. Additionally, its action on the pituitary gland can help reduce the secretion of prolactin, making it potentially useful in treating prolactinomas.
Clinical Applications[edit | edit source]
Although Delergotrile has shown promise in preclinical studies, its clinical applications are still under investigation. The drug has been evaluated in animal models for its efficacy in reducing symptoms of Parkinson's disease and its ability to lower prolactin levels. However, further clinical trials are necessary to establish its safety and effectiveness in humans.
Side Effects[edit | edit source]
As with many dopaminergic drugs, Delergotrile may cause side effects such as nausea, dizziness, and orthostatic hypotension. Long-term use can also lead to complications such as impulse control disorders and dyskinesias. It is important for patients to be monitored closely by healthcare professionals when using this medication.
Research and Development[edit | edit source]
Research on Delergotrile is ongoing, with studies focusing on optimizing its pharmacokinetic properties and reducing potential side effects. Advances in drug delivery systems and formulation techniques may enhance its therapeutic potential in the future.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
